WallStreetZenWallStreetZen

NASDAQ: SLN
Silence Therapeutics PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SLN

Based on 5 analysts offering 12 month price targets for Silence Therapeutics PLC

Min Forecast
$3.00-58.51%
Avg Forecast
$42.60+489.21%
Max Forecast
$75.00+937.34%

Should I buy or sell SLN stock?

Based on 5 analysts offering ratings for Silence Therapeutics PLC.

Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 20%
Although SLN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SLN as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their SLN stock forecasts and price targets.

SLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-16
lockedlocked$00.00+00.00%2025-08-08
lockedlocked$00.00+00.00%2025-06-13
lockedlocked$00.00+00.00%2025-05-09
lockedlocked$00.00+00.00%2025-05-09

1 of 1

Forecast return on equity

Is SLN forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is SLN forecast to generate an efficient return on assets?

SLN revenue forecast

What is SLN's revenue in the next 1 years based on estimates from 6 analysts?

Avg 1 year Forecast
$32.3M+18.18%

SLN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLN$7.23$42.60+489.21%Buy
DMAC$6.69$12.33+84.35%Strong Buy
DRTS$4.09$9.00+120.05%Buy
TECX$18.62$76.25+309.51%Strong Buy
ANNX$3.19$13.00+307.52%Buy
View Top Biotech Stocks

Silence Therapeutics Stock Forecast FAQ

Is Silence Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: SLN) stock is to Buy SLN stock.

Out of 5 analysts, 2 (40%) are recommending SLN as a Strong Buy, 2 (40%) are recommending SLN as a Buy, 0 (0%) are recommending SLN as a Hold, 0 (0%) are recommending SLN as a Sell, and 1 (20%) are recommending SLN as a Strong Sell.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.

What is SLN's revenue growth forecast for 2025-2025?

(NASDAQ: SLN) Silence Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Silence Therapeutics's revenue in 2025 is $27,369,000.

In 2025, SLN is forecast to generate $4,583,204,572 in revenue, with the lowest revenue forecast at $1,455,136,277 and the highest revenue forecast at $10,555,512,359.

What is SLN's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: SLN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 14.49%.

What is SLN's Price Target?

According to 5 Wall Street analysts that have issued a 1 year SLN price target, the average SLN price target is $42.60, with the highest SLN stock price forecast at $75.00 and the lowest SLN stock price forecast at $3.00.

On average, Wall Street analysts predict that Silence Therapeutics's share price could reach $42.60 by Sep 16, 2026. The average Silence Therapeutics stock price prediction forecasts a potential upside of 489.21% from the current SLN share price of $7.23.

What is SLN's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: SLN) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.